Acrux Ltd has released a press release.
Acrux Receives FDA Approval - Generic Testosterone Solution
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Acrux
- Acrux Ltd Share Purchase Plan Offer Booklet
- Acrux Raises $7.8m Via Placement and Announces SPP
- Acrux Signs Licensing Agreement with Dash Pharmaceuticals
- Appendix 4E and Full Year Statutory Accounts
- Acrux Signs Licensing Agreement with Harris Pharmaceutical
Later from Acrux
- Share Purchase Plan Closes Oversubscribed
- Appendix 4D and Half Year Accounts - for the 31 Dec ac
- Acrux Investor Presentation
- Acruxs fourth generic dossier accepted by FDA for review
- Acrux confirms patent challenge
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux